Pharma-funded group hired by U.K. health service to advise on strategy

The U.K.'s National Health Service hired a lobbying group, Specialised Healthcare Alliance (SHCA), to write a report on strategies for care, which could influence health policy, The Guardian reports. The deal has raised eyebrows because SHCA is entirely funded by drugmakers. Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.